Flagship invests in three principle business sectors: Therapeutics; Health Technologies; and Sustainability. Initial investments range between $250 thousand and $5 million, and we may invest up to $12-15 million during the life of a company. Click on a tab below to filter the listing of the portfolio by industry sector, or on a column heading to sort.
|Extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure.||Private||2010||View Profile|
|Developing innovative diagnostic products to improve patient health.||Public||2006||View Profile|
|Developing ground-breaking tools in high definition diagnostics.||Private||2007||View Profile|
|Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform.||Private||2007||View Profile|
|Commercializing breakthrough, innovative products in human nutrition.||Private||2012||View Profile|